Cognitive impairment associated with chronic cerebrovascular disease and treatment options to be used at pre-dementia stages

Stanislav N. Yanishevskiy , Sergey V. Vorobyev

For citation:

Abstract

Cerebrovascular diseases are among the most frequent nosological forms of modern neurology. One of the most important components of their clinical picture is cognitive impairment. At the same time, the most frequent is the development of mild and moderate cognitive disorders. This is especially true for the initial stages of the disease. The pathogenetic basis of the violation of higher cortical functions is a complex of pathophysiological and pathochemical reactions formed within the cascade of ischemic damage to the brain substance. One of the central places among them is occupied by the development of energy deficiency due to a decrease in ATP synthesis and the formation of oxidative stress. This makes it necessary to prescribe pharmacological drugs that can have a multimodal effect. Among such drugs, idebenone is distinguished, which can stimulate the mitochondrial respiratory chain and, in addition, exhibits antioxidant properties. which has demonstrated its effectiveness in the treatment of pre-segment cognitive impairment in patients with cerebrovascular pathology, especially in the framework of combined administration with drugs having other mechanisms of action.
Key words: small vessel diseases, dyscirculatory encephalopathy, cerebrovascular diseases, cognitive impairment, oxidative stress, idebenone, mitochondria, dementia.

References

1. Pais R, Ruano L, P Carvalho O, Barros H. Global Cognitive Impairment Prevalence and Incidence in Community Dwelling Older Adults-A Systematic Review. Geriatrics (Basel). 2020; 5 (4): 84. DOI: 10.3390/geriatrics5040084

2. World Health Organization Dementia, Fact Sheet on Dementia. [Accessed on 15 February 2019)] Available online: https: //www.who.int/news-room/fact-sheets/detail/dementia

3. Petersen RC, Lopez O, Armstrong MJ et al. Practice guideline update summary: mild cognitive impairment: report of the guideline development, dissemination, and implementation subcommittee of the American Academy of Neurology. Neurology. 2018; 90 (3): 126–35. DOI: 10.1212/WNL.0000000000004826

4. Petersen RC. Mild cognitive impairment. Continuum (Minneap Minn). 2016; 22 (2 Dementia): 404–18. DOI: 10.1212/CON.0000000000000313

5. Li JQ, Tan L, Wang HF et al. Risk factors for predicting progression from mild cognitive impairment to Alzheimer’s disease: a systematic review and meta-analysis of cohort studies. J Neurol Neurosurg Psychiatry. 2016; 87 (5): 476–84. DOI: 10.1136/jnnp-2014-310095

6. Левин О.С. Диагностика и лечение когнитивных нарушений и деменции в клинической практике. М.: МЕДпресс-информ, 2019.

Levin OS. Diagnosis and treatment of cognitive impairment and dementia in clinical practice. Moscow: MEDpress, 2019 (in Russian).

7. Лурия А.Р. Высшие корковые функции человека. М.: Изд. МГУ, 1962.

Luriya AR. Higher cortical functions of a person. Moscow: Izd. MGU, 1962 (in Russian).

8. Емелин А.Ю., Лобзин В.Ю., Воробьев С.В. Когнитивные нарушения: руководство для врачей. М.: Т8 Издательские Технологии, 2019.

Emelin AYu, Lobzin VYu, Vorob'ev SV. Cognitive disorders: a guide for doctors. Moscow: T8 Izdatel'skie Tekhnologii, 2019 (in Russian).

9. Боголепова А.Н., Васенина Е.Е., Захаров В.В. и др. Реабилитация высших психических функций у больных с очаговым поражением головного мозга: Клин. рекоменд. Москва: МЕДпресс-информ, 2020.

Bogolepova AN, Vasenina EE, Zaharov VV et al. Rehabilitation of higher mental functions in patients with focal brain damage: Clinical recommendations. Moscow: MEDpress-inform, 2020 (in Russian).

10. Яхно Н.Н. Когнитивные расстройства в неврологической клинике. Неврологический журнал. 2006; 11 (1): 4–12.

Yakhno NN. Cognitive impairment in neurological clinical practice. Neurological Journal. 2006; 11 (1): 4–12 (in Russian).

11. Емелин А.Ю. Возможности диагностики и лечения когнитивных нарушений на недементных стадиях. Неврология, нейропсихиатрия, психосоматика. 2020; 12 (5): 78–83. DOI: 10.14412/2074-2711-2020-5-78-83

Emelin AYu. The possibilities of diagnosing and treating cognitive impairment at non-dementia stages. Neurology, Neuropsychiatry, Psychosomatics. 2020; 12 (5): 78–83. DOI: 10.14412/2074-2711-2020-5-78-83 (in Russian).

12. Petersen RS, Touchon J. Consensus on mild cognitive impairment. Research and practice in AD. EADS-ADCS joint meeting 2005; 10: 38–46. DOI: 10.3233/JAD-190828

13. Старчина Ю.А., Захаров В.В. Степень тяжести и терапия когнитивных нарушений. Неврология, нейропсихиатрия, психосоматика. 2021; 13 (3): 119–24. DOI: 10.14412/2074-2711-2021-3-119-124

Starchina YuА, Zakharov VV. Severity and treatment of cognitive impairment. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2021; 13 (3): 119–24. DOI: 10.14412/2074-2711-2021-3-119-124 (in Russian).

14. Левин О.С. Диагностика и лечение деменции в клинической практике. М.: МЕДпресс, 2010.

Levin OS. Diagnosis and treatment of cognitive impairment and dementia in clinical practice. Moscow: MEDpress, 2010 (in Russian).

15. McKhann GM, Knopman DS, Chertkow H et al. The diagnosis of dementia due to Alzheimer's disease: recommendations from the National Institute on Aging-Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease. Alzheimers Dement. 2011; 7 (3): 263–9. DOI: 10.1016/j.jalz.2011.03.005

16. Локшина А.Б. Тяжелая деменция: диагностика, ведение пациентов, профилактика осложнений. Неврология, нейропсихиатрия, психосоматика. 2014; 1: 54–60.

Lokshina AB. Severe dementia: diagnosis, patient management, prevention of complications. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2014; 1: 54–60 (in Russian).

17. Суслина З.А., Гулевская Т.С., Максимова М.Ю., Моргунов В.А. Нарушения мозгового кровообращения: диагностика, лечение, профилактика. М.: МЕДпресс-информ, 2016.

Suslina ZA, Gulevskaya TS, Maksimova MYu, Morgunov VA. Moscow: MEDpress-inform, 2016 (in Russian).

18. Трусова Н.А., Левина Н.О., Левин О.С. Дисциркуляторная энцефалопатия – letzte Wiese отечественной ангионеврологии. Современная терапия в психиатрии и неврологии. 2016; 2: 11–7.

Trusova NA, Levina NO, Levin OS. Dyscirculatory encephalopathy – letzte Wiese of domestic angioeducology. Modern therapy in psychiatry and neurology. 2016; 2: 11–7 (in Russian).

19. Парфенов В.А. Дисциркуляторная энцефалопатия и сосудистые когнитивные расстройства. М.: ИМА-ПРЕСС, 2017.

Parfenov VA. Dyscirculatory encephalopathy and vascular cognitive disorders. Moscow: IMA-PRESS, 2017 (in Russian).

20. Емелин А.Ю., Лобзин В.Ю. Возможности медикаментозной терапии сосудистых когнитивных нарушений: критический взгляд и возможные компромиссы. Неврология, нейропсихиатрия, психосоматика. 2020; 12 (4): 131–6. DOI: 10.14412/2074-2711-2020-4-

131–6

Emelin AYu, Lobzin VYu. Possibilities of drug therapy for vascular cognitive impairment: a critical view and possible compromises. Nevrologiya, neiropsikhiatriya, psikhosomatika = Neurology, Neuropsychiatry, Psychosomatics. 2020; 12 (4): 131–6. DOI: 10.14412/2074-2711-2020-4-131–6 (in Russian).

21. Farooq MU, Min J, Goshgarian C, Gorelick PB. Pharmacotherapy for Vascular Cognitive Impairment. CNS Drugs. 2017; 31 (9): 759–76. DOI: 10.1007/s40263-017-0459-3

22. Камчатнов П.Р., Черемин Р.А., Скипетрова Л.А., Чугунов А.В. Когнитивные нарушения сосудистого генеза в практике терапевта. Терапия. 2022; 8 (9): 152–62. DOI: 10.18565/therapy.2022.9.152–162

Kamchatnov PR, Cheremin RA, Skipetrova LA, Chugunov AV. Cognitive disorders of vascular genesis in the practice of a therapist. Therapy. 2022; 8 (9): 152–62. DOI: 10.18565/therapy.2022.9.152–162 (in Russian).

23. Гривенникова В.Г., Виноградов А.Д. Генерация активных форм кислорода митохондриями. Успехи биологической химии. 2013; 53: 245–96.

Grivennikova VG, Vinogradov AD. Generation of reactive oxygen species by mitochondria. Biological chemistry reviews. 2013; 53: 245–96 (in Russian).

24. Рачин А.П., Аверченкова А.А. Идебенон (нобен) – от теории к практике. Журнал неврологии и психиатрии им. С.С. Корсакова. 2011; 111 (5): 81–4.

Rachin AP, Averchenkova AA. Idebenone (noben) – from theory to practice. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2011; 111 (5): 81–4 (in Russian).

25. Montenegro L, Turnaturi R, Parenti C, Pasquinucci L. Idebenone: Novel Strategies to Improve Its Systemic and Local Efficacy. Nanomaterials (Basel). 2018; 8 (2): 87. DOI: 10.3390/nano8020087

26. Румянцева С.А., Федин А.И., Сохова О.Н. Антиоксидантная терапия ишемических повреждений головного мозга. Журнал неврологии и психиатрии им. С.С. Корсакова. 2011; 2 (4): 28–31.

Rumyanceva SA, Fedin AI, Sohova ON. Antioxidant therapy of ischemic brain damage. Zhurnal Nevrologii i Psikhiatrii imeni S.S. Korsakova. 2011; 2 (4): 28–31 (in Russian).

27. Bodmer M, Vankan P, Dreier M et al. Pharmacokinetics and metabolism of idebenone in healthy male subjects. Eur J Clin Pharmacol. 2009; 65 (5): 493–501. DOI: 10.1007/s00228-008-0596-1

28. Becker C, Bray-French K, Drewe J. Pharmacokinetic evaluation of idebenone. Expert Opin Drug Metab Toxicol. 2010; 6 (11): 1437–44. DOI: 10.1517/17425255.2010.530656

29. Музыченко А.П., Краснослободцева Л.А., Лубсанова С.В. Клиническое действие Нобена при органическом эмоционально-лабильном (астеническом) расстройстве. Нервные болезни. 2008; 1: 15–7.

Muzychenko AP, Krasnoslobodceva LA, Lubsanova SV. Clinical effect of Noben in organic emotionally labile (asthenic) disorder. Nervous diseases. 2008; 1: 15–7 (in Russian).

30. Боголепова А.Н., Коваленко Е.А. Терапия астенических и когнитивных нарушений при хронической ишемии головного мозга: возможности идебенона. Доктор.Ру. 2016; 4 (121): 10–3.

Bogolepova AN, Kovalenko EA. Treating asthenia and cognitive impairment in patients with chronic cerebral ischemia: idebenone's potential. Doctor.ru. 2016; 4 (121): 10–3 (in Russian).

31. Исаев Н.К., Стельмашук Е.В., Генрихс Е.Е. Роль фактора роста нервов в пластических перестройках холинергических нейронов базальных ядер переднего мозга. Биохимия. 2017; 82 (3): 429–40.

Isaev NK, Stelmashook EV, Genrikhs EE. Role of nerve growth factor in plasticity of forebrain cholinergic neurons. Biochemistry (Мoscow). 2017; 82 (3): 429–40 (in Russian).

32. Табеева Г.Р. Роль цереброваскулярной патологии в развитии деменции смешанного генеза. РМЖ. 2018; 12 (I): 16–20.

Tabeeva GR. Role of cerebrovascular disease in the development of mixed dementia. Russian Medical Journal. 2018; 12 (I): 16–20 (in Russian).

33. Bergamasco B, Villardita C, Coppi R. Effects of idebenone in elderly subjects with cognitive decline. Results of a multicentre clinical trial. Arch Gerontol Geriatr. 1992 Nov-Dec; 15 (3): 279–86. DOI: 10.1016/0167-4943 (92)90063-a

34. Lingetti M, Porfido FA, Ciarimboli M et al. Evaluation of the clinical efficacy of idebenone in patients affected by chronic cerebrovascular disorders. Arch Gerontol Geriatr. 1992 Nov-Dec; 15 (3): 225–37. DOI: 10.1016/0167-4943 (92)90058-c

35. Екушева Е.В. Когнитивные нарушения – актуальная междисциплинарная проблема. РМЖ. 2018; 12 (I): 32–7.

Ekusheva EV. Cognitive impairment – relevant interdisciplinary problem. Russian Medical Journal. 2018; 12 (I): 32–7 (in Russian).

36. Замерград М.В., Левин О.С. Головокружение при дисциркуляторной энцефалопатии. Фармакология и фармакотерапия. 2021; 1: 10–8. DOI: 10.46393/2713-2129_2021_1_10-18

Zamergrad MV, Levin OS. Dizziness in dyscirculatory encephalopathy. Pharmacology and Pharmacotherapy. 2021; 1: 10–8. DOI: 10.46393/2713-2129_2021_1_10-18 (in Russian).

For citation:Yanishevskiy S.N., Vorobyov S.V. Cognitive impairment associated with chronic cerebrovascular disease and treatment options to be used at pre-dementia stages. Clinical review for general practice. 2023; 4 (7): 50–58 (In Russ.). DOI: 10.47407/kr2023.4.7.00286

All accepted articles publish licensed under a Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) which allows users to read, copy, distribute and make derivative works for non-commercial purposes from the material, as long as the author of the original work is cited properly.

Clinical review for general practice